Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis

Objectives To investigate associations between cardiometabolic comorbidities and clinical characteristics, prescription patterns and retention of first biologic/targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) in patients with psoriatic arthritis (PsA).Methods Patients with PsA i...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Fabrizio Conti, Bente Glintborg, Merete Lund Hetland, Brigitte Michelsen, Elsa Vieira-Sousa, Florenzo Iannone, Ziga Rotar, Catalin Codreanu, Anne Gitte Loft, Gary J Macfarlane, Gareth T Jones, Mikkel Østergaard, Jakub Zavada, Bjorn Gudbjornsson, Lykke Midtbøll Ørnbjerg, Daniela Di Giuseppe, Miguel Bernardes, Isabel Castrejón, Laura Kuusalo, Raphael Micheroli, Burkhard Möller, Sella Aarrestad Provan, Vappu Rantalaiho, Anne C Regierer, Signe Møller-Bisgaard, Kasper Yde Jensen, Pavel Horak, Sigrid Vorobjov, Pawel Mielnik, Marleen van de Sande, Pasoon Hellamand, Lucia Otero-Varela, Handan Yarkan-Tuğsal, Katja Perdan Pirkmajer, Karin Lass, Andreas Reich, Jacob Brauner Jørgensen, Jette Heberg, Zohra Faizy Ahmadzay, Mehrdad Shoae Kazemi, Parham Karimi Reikandeh
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 2026-05-01
Edice:	RMD Open
On-line přístup:	https://rmdopen.bmj.com/content/12/2/e006477.full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!